Stocks in Focus: API Technologies (NASDAQ:ATNY), Intercept Pharmaceuticals (NASDAQ:ICPT), OvaScience (NASDAQ:OVAS), Charles & Colvard Ltd. (NASDAQ:CTHR)

API Technologies Corp. (NASDAQ:ATNY), a leading provider of high performance RF/microwave, power, and security solutions for critical and high-reliability applications, announced today the launch of configurable frequency synthesizers (Models LCFS-X), the newest addition to the Company’s line of standard RF / microwave products. API Technologies Corp. (NASDAQ:ATNY) belongs to Technology sector. Its net profit margin is -7.90% and weekly performance is 0.00%. On last trading day company shares ended up $2.06. API Technologies Corp. (NASDAQ:ATNY) distance from 50-day simple moving average (SMA50) is -15.77%.

Intercept Pharmaceuticals Inc. (ICPT) reported second quarter EPS of $1.51 after the close Monday, compared to the loss of $0.79 in the prior year period. Analysts had expected a loss of $0.12 per share. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) shares advanced 16.59% in last trading session and ended the day at $276.52. ICPT return on assets is -205.10%. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) quarterly performance is 6.58%.

OvaScience, Inc. (NASDAQ:OVAS) currently has a Zacks Rank #3 (Hold). On 12 August, OvaScience, Inc. (NASDAQ:OVAS) shares advanced 1.20% and was closed at $10.94. OVAS EPS growth in last 5 year was 0.00%. OvaScience, Inc. (NASDAQ:OVAS) year to date (YTD) performance is 19.69%.

Charles & Colvard (NASDAQ:CTHR) Director Anne M. Butler purchased 35,800 shares of Charles & Colvard stock on the open market in a transaction that occurred on Monday, August 11th. The stock was purchased at an average cost of $1.89 per share, for a total transaction of $67,662.00. Following the completion of the acquisition, the director now directly owns 112,581 shares of the company’s stock, valued at approximately $212,778. The purchase was disclosed in a filing with the SEC. Charles & Colvard Ltd. (NASDAQ:CTHR) shares advanced 2.09% in last trading session and ended the day on $1.95. CTHR Gross Margin is 41.20% and its return on assets is -13.50%. Charles & Colvard Ltd. (NASDAQ:CTHR) quarterly performance is -9.30%.